Geftib 250mg Tablet (Gefitinib) – Targeted Lung Cancer Treatment

Geftib 250mg contains Gefitinib, a potent EGFR tyrosine kinase inhibitor used to treat non-small cell lung cancer (NSCLC). It works by blocking cancer cell growth signals, making it an effective targeted therapy for patients with EGFR mutation-positive tumors.

Key Benefits:
✔️ Treats metastatic NSCLC
✔️ EGFR mutation-specific therapy
✔️ Improves progression-free survival
✔️ Convenient once-daily oral dosage

Dosage: Take 1 tablet daily as prescribed by an oncologist.

Side Effects: Common side effects include diarrhea, skin rash, dry skin, nausea, and fatigue. Consult a doctor for severe reactions.

Storage: Store below 30°C in a dry place.

FAQ Section:

Q: What is Geftib 250mg used for?
A: It is used for EGFR-positive non-small cell lung cancer (NSCLC).

Q: How should I take Geftib?
A: Take 1 tablet daily, with or without food, as prescribed.

Q: Are there any side effects?
A: Common side effects include rash, diarrhea, and fatigue. Seek medical help if severe.

Q: Can I buy Geftib 250mg without a prescription?
A: No, it is a prescription-only medication.

Q: Is Geftib a chemotherapy drug?
A: No, it is a targeted therapy that specifically blocks cancer cell growth signals.